In this article
If you've ever caught yourself scrolling through supplier catalogs the same way someone hunts for rare Pokemon, you're not alone. The peptide research community has a running joke: peptides are basically Pokemon for grown-ups. But there's a real reason this comparison sticks, and understanding it makes you a better researcher.
Just Like Pokemon, Peptides Come in Families
Pokemon are organized into "types", fire, water, electric, and so on. Peptides work the same way. They group into families based on what they're made of and how they behave.
For example, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) both come from the same family. They share part of their genetic blueprint, just like Charizard and Charmander both belong to the fire type. They're related, but they're not identical.
This matters at the bench because peptides from the same family often share similar handling needs. They may have comparable stability profiles, similar storage requirements, and related behavior in solution. When you're working with a new peptide you've never touched before, knowing its family gives you a solid first guess about how to store it, how long it might last once reconstituted, and what diluent works best.

Each One Has a "Nickname" and a Real Name
Pokemon have their species name (like "Pikachu") and a scientific classification. Peptides work the same way. Your peptide might be called "CJC-1295", that's its nickname, the name researchers use in conversation and papers. But its full legal name is something like "Tetrasubstituted GRF(1-29)." Nobody says that at the bench, but it tells you exactly what's in the vial.
The number in a peptide name usually tells you how many building blocks (called amino acids) it contains. CJC-1295 has 29 amino acids. Some peptides are short, just a few links in the chain. Others are long, with dozens of links. This affects everything from how you reconstitute it to how it behaves once dissolved.
Short peptides (under 10 amino acids) tend to be more stable in solution. Long peptides (over 20 amino acids) are more fragile. They're more likely to clump together, stick to the sides of your vial, or lose their shape. Knowing whether you're handling a shortie or a long chain changes how carefully you pipette, how vigorously you vortex, and how fast you use it once mixed.

The "Rarity" Factor, Why Some Cost More
In Pokemon, some creatures are common in the wild and others only appear under special conditions. Peptides work similarly. A simple, straightforward peptide that dozens of manufacturers can produce costs less. A peptide with an unusual sequence, one that requires more complex chemistry to build, or one with tight purity requirements costs more.
Purity isn't optional, but it's also not the whole story. A 98% pure peptide isn't automatically "better" than a 95% one for your purposes. What matters is what the 2-5% of impurities actually are. For some research applications, those impurities don't matter. For others, they could throw off your results. Always match your purity specification to your experimental needs, not to some abstract standard of "highest is best."
Building Your Research "Team"
Serious Pokemon players don't just grab random creatures, they build a team that covers different weaknesses. Serious peptide researchers do the same. You might keep GLP-1 analogs on hand for metabolic work, a stable growth hormone releasing peptide for studies requiring longer half-lives, and a short research peptide for quick tests.
Each one needs its own storage plan. Some require freezing at -20°C or colder. Others do fine refrigerated. Some need protection from light. These aren't arbitrary rules, they're based on the peptide's chemical structure and how that structure falls apart over time. Treat them individually, and you'll get consistent results. Treat them all the same way, and you'll waste money on degraded material.
The Pokemon comparison isn't just a fun way to pass time between experiments. It's a useful mental model. Peptides are a vast, varied, sometimes confusing world. Grouping them into families, understanding their names, knowing which are common and which are rare, and planning your "team" accordingly, that's what separates a researcher who burns through vials quickly from one who gets the most out of every expensive gram.
Now go catch 'em all.
Frequently asked questions
Why do some peptides cost more than others?
Peptides with unusual sequences, complex chemistry, or strict purity requirements cost more to manufacture, similar to rare Pokemon.
Does peptide length affect how I should handle it?
Yes. Short peptides (under 10 amino acids) are generally more stable. Long peptides (over 20) are more fragile and prone to clumping or degradation.
Should I always buy the highest purity available?
Match purity to your experiment's needs. Higher purity costs more, but 95% pure is sufficient for many applications if the impurities don't affect your results.
Related from our lab: the pen · cartridges · bacteriostatic water · reconstitution calculators
Shared by PreppinPeppers for research, educational, and demonstration awareness only. We link to third-party coverage; we do not endorse it, and nothing here is medical advice or a recommendation to use any substance in humans or animals. Our products are sold for laboratory research use only.
What the research community gets wrong about peptide families and naming
Even careful researchers repeat a few myths about how peptides are grouped, named, and handled at the bench. Here are the ones worth correcting.
- "Higher purity is always better." A 98% peptide is not automatically more useful than a 95% one for your work. What matters is what the remaining few percent actually are and whether those specific impurities interfere with your assay. Match the purity spec to the experiment, not to the biggest number on the sheet.
- The number in a name is not a dose or a potency rating. The "1" in GLP-1 marks its place in a family, and the "1295" in CJC-1295 is a registry-style label, not a strength. Names tell you identity and sequence, not how much material is in the vial.
- Same family does not mean same handling. Knowing a peptide's family (for example, GLP-1 and GIP share a lineage) gives you a reasonable first guess about storage and stability. It is a starting point, not a rule. Confirm each peptide's own conditions from its documentation before you store or reconstitute it.
- Vortexing harder does not "help" a stubborn peptide dissolve. Work on protein solutions found that air/liquid interfaces and cavitation drive aggregation more than shear alone. Foaming and a hard vortex can damage material rather than rescue it. Swirl gently and let it go into solution.
- Length is a guide, not a guarantee. Short chains are often more stable and long chains more fragile, but sequence and storage conditions still decide the outcome. Do not assume a short peptide is indestructible or that a long one is doomed.
From our bench: Have you reconstituted the same peptide two ways, one with a gentle swirl and one with a hard vortex, and then watched both vials over the next several days? If you logged what you saw (clarity versus haze, any film or bubbles gathering at the liquid surface, anything settling at the bottom), send us your side-by-side notes along with the peptide and diluent you used. We will add real bench observations here instead of guesses.
Sources
- Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
- Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
- Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
- PubChem: Glucagon-like peptide 1 (GLP-1), CID 16133831 (National Library of Medicine)
- PubChem: CJC-1295, CID 91971820 (National Library of Medicine)
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.